The healthcare stocks declined, with vaccine-related companies being notable losers after Pfizer's released data that its Covid-19 pill could reduce hospitalisations and deaths in high-risk patients. Pfizer Inc said its experimental antiviral pill to treat COVID-19 cut by 89% the chance of hospitalization or death for adults at risk of the severe disease. Cansino Biologics Inc, one of China's COVID-19 vaccine makers, slumped more than 17%.
Shares of Tech companies also dropped, with Alibaba Group while its health unit lost 1.2%. Meituan tumbled 2%, while Tencent Holdings retreated 0.8%.
Gaming stocks surged, with Sands China up 7.7%, as solid gaming revenue data in Macau reflects the gradual recovery in visitor arrivals.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
